140 related articles for article (PubMed ID: 26802052)
1. The role of Matriptase-2 during the early postnatal development in humans.
De Falco L; Bruno M; Yilmaz-Keskin E; Sal E; Büyükavci M; Kaya Z; Girelli D; Iolascon A
Haematologica; 2016 Apr; 101(4):e126-8. PubMed ID: 26802052
[No Abstract] [Full Text] [Related]
2. Haematologic data, iron parameters and molecular findings in two new cases of iron-refractory iron deficiency anaemia.
Tchou I; Diepold M; Pilotto PA; Swinkels D; Neerman-Arbez M; Beris P
Eur J Haematol; 2009 Dec; 83(6):595-602. PubMed ID: 19708871
[TBL] [Abstract][Full Text] [Related]
3. Normalizing hepcidin predicts
Heeney MM; Guo D; De Falco L; Campagna DR; Olbina G; Kao PP; Schmitz-Abe K; Rahimov F; Gutschow P; Westerman K; Ostland V; Jackson T; Klaassen RJ; Markianos K; Finberg KE; Iolascon A; Westerman M; London WB; Fleming MD
Blood; 2018 Jul; 132(4):448-452. PubMed ID: 29895660
[No Abstract] [Full Text] [Related]
4. Two nonsense mutations in the TMPRSS6 gene in a patient with microcytic anemia and iron deficiency.
Guillem F; Lawson S; Kannengiesser C; Westerman M; Beaumont C; Grandchamp B
Blood; 2008 Sep; 112(5):2089-91. PubMed ID: 18596229
[TBL] [Abstract][Full Text] [Related]
5. Iron-refractory iron deficiency anemia (IRIDA) cases with 2 novel TMPRSS6 mutations.
Sal E; Keskin EY; Yenicesu I; Bruno M; De Falco L
Pediatr Hematol Oncol; 2016 Apr; 33(3):226-32. PubMed ID: 27120435
[TBL] [Abstract][Full Text] [Related]
6. Responsiveness to oral iron and ascorbic acid in a patient with IRIDA.
Cau M; Galanello R; Giagu N; Melis MA
Blood Cells Mol Dis; 2012 Feb; 48(2):121-3. PubMed ID: 22169218
[TBL] [Abstract][Full Text] [Related]
7. [Iron deficiency anaemia due to a matriptase-2 mutation].
Cuijpers ML; Wiegerinck ET; Brouwer R; de Witte TJ; Swinkels DW
Ned Tijdschr Geneeskd; 2010; 154():A1038. PubMed ID: 20719010
[TBL] [Abstract][Full Text] [Related]
8. A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron.
Melis MA; Cau M; Congiu R; Sole G; Barella S; Cao A; Westerman M; Cazzola M; Galanello R
Haematologica; 2008 Oct; 93(10):1473-9. PubMed ID: 18603562
[TBL] [Abstract][Full Text] [Related]
9. Two novel mutations in TMPRSS6 associated with iron-refractory iron deficiency anemia in a mother and child.
Yaish HM; Farrell CP; Christensen RD; MacQueen BC; Jackson LK; Trochez-Enciso J; Kaplan J; Ward DM; Salah WK; Phillips JD
Blood Cells Mol Dis; 2017 Jun; 65():38-40. PubMed ID: 28460265
[TBL] [Abstract][Full Text] [Related]
10. [Identification and characterization of clinical features and gene mutation in a patient with iron refractory iron deficiency anemia (IRIDA)].
Xiong Y; Yang W; Li Y; Peng G; Li Y; Fan H; Ye L; Song L; Zhao X; Li J; Jing L; Zhang L; Zhou K; Xu Y; Zhang F
Zhonghua Xue Ye Xue Za Zhi; 2014 Jun; 35(6):486-90. PubMed ID: 24985168
[TBL] [Abstract][Full Text] [Related]
11. Iron-refractory iron deficiency anemia.
Finberg KE
Semin Hematol; 2009 Oct; 46(4):378-86. PubMed ID: 19786206
[TBL] [Abstract][Full Text] [Related]
12. Is the acronym IRIDA acceptable for slow responders to iron in the presence of TMPRSS6 mutations?
Yilmaz-Keskin E; Sal E; de Falco L; Bruno M; Iolascon A; Koçak U; Yenicesu I
Turk J Pediatr; 2013; 55(5):479-84. PubMed ID: 24382527
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of the defective hepcidin inhibition in TMPRSS6 mutations associated with iron-refractory iron deficiency anemia.
Silvestri L; Guillem F; Pagani A; Nai A; Oudin C; Silva M; Toutain F; Kannengiesser C; Beaumont C; Camaschella C; Grandchamp B
Blood; 2009 May; 113(22):5605-8. PubMed ID: 19357398
[TBL] [Abstract][Full Text] [Related]
14. Increased susceptibility to iron deficiency of Tmprss6-haploinsufficient mice.
Nai A; Pagani A; Silvestri L; Camaschella C
Blood; 2010 Aug; 116(5):851-2. PubMed ID: 20688966
[No Abstract] [Full Text] [Related]
15. Iron Refractory Iron Deficiency Anemia Due to 374 Base Pairs Deletion in the TMPRSS6 Gene.
Çakmakli S; Acipayam C; Yenmiş İnan MN; Doğan H
J Pediatr Hematol Oncol; 2019 Jul; 41(5):e333-e335. PubMed ID: 30130276
[TBL] [Abstract][Full Text] [Related]
16. Matriptase-2 is essential for hepcidin repression during fetal life and postnatal development in mice to maintain iron homeostasis.
Willemetz A; Lenoir A; Deschemin JC; Lopez-Otin C; Ramsay AJ; Vaulont S; Nicolas G
Blood; 2014 Jul; 124(3):441-4. PubMed ID: 24904115
[TBL] [Abstract][Full Text] [Related]
17. [IRIDA: what's new].
Nafil H; Tazi I; Mahmal L
Ann Biol Clin (Paris); 2012; 70(3):359-60. PubMed ID: 22826848
[No Abstract] [Full Text] [Related]
18. A child with severe iron-deficiency anemia and a complex TMPRSS6 genotype.
Capra AP; Ferro E; Cannavò L; La Rosa MA; Zirilli G
Hematology; 2017 Oct; 22(9):559-564. PubMed ID: 28447549
[TBL] [Abstract][Full Text] [Related]
19. Into the matrix: regulation of the iron regulatory hormone hepcidin by matriptase-2.
Knutson MD
Nutr Rev; 2009 May; 67(5):284-8. PubMed ID: 19386032
[TBL] [Abstract][Full Text] [Related]
20. Matriptase-2 mutations in iron-refractory iron deficiency anemia patients provide new insights into protease activation mechanisms.
Ramsay AJ; Quesada V; Sanchez M; Garabaya C; Sardà MP; Baiget M; Remacha A; Velasco G; López-Otín C
Hum Mol Genet; 2009 Oct; 18(19):3673-83. PubMed ID: 19592582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
